565 related articles for article (PubMed ID: 15329109)
1. Histopathological and immunohistochemical study of papillary urothelial neoplasms of low malignant potential and grade associated with extensive invasive low-grade urothelial carcinoma.
Mai KT; Elmontaser G; Perkins DG; Yazdi HM; Stinson WA; Thijssen A
BJU Int; 2004 Sep; 94(4):544-7. PubMed ID: 15329109
[TBL] [Abstract][Full Text] [Related]
2. Large nested variant of urothelial carcinoma: 23 cases mimicking von Brunn nests and inverted growth pattern of noninvasive papillary urothelial carcinoma.
Cox R; Epstein JI
Am J Surg Pathol; 2011 Sep; 35(9):1337-42. PubMed ID: 21836490
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
Chang WC; Chang YH; Pan CC
Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
[TBL] [Abstract][Full Text] [Related]
4. Significance of denuded urothelium in papillary urothelial lesions.
Owens CL; Epstein JI
Am J Surg Pathol; 2007 Feb; 31(2):298-303. PubMed ID: 17255776
[TBL] [Abstract][Full Text] [Related]
5. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
Samaratunga H; Khoo K
Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
Guo CC; Fine SW; Epstein JI
Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
[TBL] [Abstract][Full Text] [Related]
7. Polypoid/papillary cystitis: a series of 41 cases misdiagnosed as papillary urothelial neoplasia.
Lane Z; Epstein JI
Am J Surg Pathol; 2008 May; 32(5):758-64. PubMed ID: 18379418
[TBL] [Abstract][Full Text] [Related]
8. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
Tamas EF; Epstein JI
Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
[TBL] [Abstract][Full Text] [Related]
9. Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder.
Pich A; Chiusa L; Formiconi A; Galliano D; Bortolin P; Comino A; Navone R
Cancer; 2002 Aug; 95(4):784-90. PubMed ID: 12209722
[TBL] [Abstract][Full Text] [Related]
10. Invasive low-grade papillary urothelial carcinoma: a clinicopathologic analysis of 41 cases.
Toll AD; Epstein JI
Am J Surg Pathol; 2012 Jul; 36(7):1081-6. PubMed ID: 22510761
[TBL] [Abstract][Full Text] [Related]
11. Urothelial carcinoma with abundant myxoid stroma.
Tavora F; Epstein JI
Hum Pathol; 2009 Oct; 40(10):1391-8. PubMed ID: 19535127
[TBL] [Abstract][Full Text] [Related]
12. Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 30 pure and mixed cases.
Wasco MJ; Daignault S; Bradley D; Shah RB
Hum Pathol; 2010 Feb; 41(2):163-71. PubMed ID: 19800100
[TBL] [Abstract][Full Text] [Related]
13. Bladder cancer in Sri Lanka: experience from a tertiary referral center.
Goonewardena SA; De Silva WA; De Silva MV
Int J Urol; 2004 Nov; 11(11):969-72. PubMed ID: 15509199
[TBL] [Abstract][Full Text] [Related]
14. Nested variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of 12 cases.
Lin O; Cardillo M; Dalbagni G; Linkov I; Hutchinson B; Reuter VE
Mod Pathol; 2003 Dec; 16(12):1289-98. PubMed ID: 14681330
[TBL] [Abstract][Full Text] [Related]
15. Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification.
Fine SW; Humphrey PA; Dehner LP; Amin MB; Epstein JI
J Urol; 2005 Nov; 174(5):1976-80. PubMed ID: 16217372
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
[TBL] [Abstract][Full Text] [Related]
17. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
[TBL] [Abstract][Full Text] [Related]
18. E-cadherin cell-adhesion molecule expression as a diagnostic adjunct in urothelial cytology.
Ross JS; Cheung C; Sheehan C; del Rosario AD; Bui HX; Fisher HA
Diagn Cytopathol; 1996 Jun; 14(4):310-5. PubMed ID: 8725130
[TBL] [Abstract][Full Text] [Related]
19. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma.
Coblentz TR; Mills SE; Theodorescu D
Cancer; 2001 Apr; 91(7):1284-90. PubMed ID: 11283928
[TBL] [Abstract][Full Text] [Related]
20. Urothelial (transitional cell) papilloma of the urinary bladder: a clinicopathologic study of 26 cases.
McKenney JK; Amin MB; Young RH
Mod Pathol; 2003 Jul; 16(7):623-9. PubMed ID: 12861056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
